Skip to main content
. 2022 Sep 30;13:1020123. doi: 10.3389/fphar.2022.1020123

FIGURE 2.

FIGURE 2

Atovaquone Plasma Concentration. Atovaquone plasma concentration measured at day 3 and 5 following initiation of therapy. Day 3 drug levels were significantly lower than those of day 5. (**p < 0.005).